Medical device companies are accelerating away from fragmented legacy quality and PLM systems in favor of integrated, AI-powered development environments. Today, Enlil announced a record Q1 2026, signing eight new MedTech customers across organ perfusion, surgical robotics, cardiovascular technology, women’s health, AI-driven imaging, Software as a Medical Device, and more. The companies selected Enlil’s AI-powered traceability platform to unify quality, product lifecycle, risk, procurement, supplier management, and regulatory readiness workflows within a single connected system. The momentum reflects a broader MedTech shift toward platforms designed for modern, fast-moving product development and AI-enabled compliance. #MedTech #MedicalDevices #AI #PLM #QualityManagement #RegulatoryAffairs #DigitalTransformation #SoftwareAsAMedicalDevice #Enlil #Q12026Wins #MedTechNews